









Markets
/
Stocks
/
nasdaq-asth
/

Astrana Health Inc

ASTH

31.260USD

-0.550-1.73%

Market hours （ET）Quotes delayed by 15 min

1.54BMarket Cap

60.82P/E TTM



Astrana Health Inc

31.260

-0.550-1.73%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Astrana Health Inc

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Astrana Health Inc's Score

Industry at a Glance

Industry Ranking

19 / 78

Overall Ranking

99 / 4621

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 10 analysts

Buy

Current Rating

45.000

Target Price

+35.34%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Astrana Health Inc Highlights

StrengthsRisks

Astrana Health, Inc. is a healthcare company. The Company provides care coordination services to each constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's Care Enablement segment is an integrated, end-to-end clinical and administrative platform, powered by its technology suite, which provides operational, clinical, financial, technology, management, and strategic services. Its Care Partners segment is focused on building and managing provider networks by partnering with provider partners for coordinated care delivery. Its Care Delivery segment is a data-driven care delivery organization focused on delivering accessible care to all patients. Its care delivery organization includes primary care, multi-specialty care, and ancillary care services.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 77.82% year-on-year.

Overvalued

The company’s latest PE is 61.21, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 26.56M shares, decreasing 8.05% quarter-over-quarter.

Held by John Hussman

Star Investor John Hussman holds 126.00K shares of this stock.

Higher Market Activity

The company has more investor interest, with a 20-day turnover ratio of 0.83.

Financial Health

Currency: USD Updated: 2025-10-30

The company's current financial score is 9.61, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 654.81M, representing a year-over-year increase of 34.66%, while its net profit experienced a year-over-year increase of 50.85%.

Score

Industry at a Glance

Previous score

9.61

Change



Financials

9.87

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.62

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

9.87

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.69

Key Metrics

Free cash flow

No Data

Astrana Health Inc's Company Valuation

Currency: USD Updated: 2025-10-30

The company’s current valuation score is 7.78, which is higher than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 61.21, which is 6.54% below the recent high of 65.21 and 60.39% above the recent low of 24.24.

Score

Industry at a Glance

Previous score

7.78

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 19/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-30

The company’s current earnings forecast score is 8.60, which is higher than the Healthcare Providers & Services industry's average of 7.60. The average price target for Astrana Health Inc is 45.00, with a high of 54.00 and a low of 36.00.

Score

Industry at a Glance

Previous score

8.60

Change

Support & Resistance

No Data

Analyst Rating

Based on 10 analysts

Buy

Current Rating

45.000

Target Price

+35.34%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Astrana Health Inc

ASTH

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-30

The company’s current price momentum score is 7.24, which is higher than the Healthcare Providers & Services industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 35.11 and the support level at 28.19, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.90

Change

-1.66

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.107

Buy

RSI(14)

53.321

Neutral

STOCH(KDJ)(9,3,3)

35.910

Sell

ATR(14)

1.236

High Vlolatility

CCI(14)

9.378

Neutral

Williams %R

49.917

Neutral

TRIX(12,20)

0.602

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

33.060

Sell

MA10

32.973

Sell

MA20

31.459

Sell

MA50

30.318

Buy

MA100

27.734

Buy

MA200

29.575

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-30

The company’s current institutional recognition score is 5.00, which is lower than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 53.20%, representing a quarter-over-quarter decrease of 29.59%. The largest institutional shareholder is The Vanguard, holding a total of 4.82M shares, representing 9.66% of shares outstanding, with 0.97% decrease in holdings.

Score

Industry at a Glance

Previous score

5.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Allied Physicians of California, A Professional Medical Corporation

6.13M

-10.24%

BlackRock Institutional Trust Company, N.A.

5.53M

-4.93%

The Vanguard Group, Inc.

Star Investors

4.82M

-1.34%

State Street Investment Management (US)

1.60M

+0.06%

Lam (Thomas S)

1.56M

+1.71%

Sim (Brandon)

1.44M

-9.40%

Sim (Kenneth T)

1.43M

+1.87%

Dimensional Fund Advisors, L.P.

1.26M

+12.92%

Fidelity Management & Research Company LLC

1.19M

-22.39%

Geode Capital Management, L.L.C.

1.05M

-1.29%

Risk Assessment

Currency: USD Updated: 2025-10-30

The company’s current risk assessment score is 4.97, which is lower than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 0.81. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.